Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,245 across all filing types
Latest filing 2023-06-02 Share Issue/Capital Cha…
Country IN India
Listing BSE.NS BLISSGVS

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
ESOP/ESOS/ESPS
Share Issue/Capital Change Classification · 95% confidence The document is a formal notification addressed to stock exchanges regarding the allotment of shares under an Employee Stock Options Plan (ESOP). It details the number of shares allotted, the increase in issued share capital, regulatory references to SEBI regulations, and specifics about the shares such as lock-in period and ISIN. There are no financial statements or comprehensive financial data presented, nor is this a report or presentation. The document is an announcement of a capital change due to ESOP share allotment, which fits the category of Share Issue/Capital Change (SHA). The document length is under 5,000 characters and is a direct communication of share allotment, not a report publication or certification. Therefore, the appropriate classification is SHA with high confidence.
2023-06-02 English
We would like to inform you that, the ESOP Allotment Committee of the Company at its meeting held on June 02, 2023, has approved the allotment of 44,500 equity shares of face value of Re. ....
Share Issue/Capital Change Classification · 100% confidence The document is a formal notification addressed to stock exchanges regarding the allotment of shares under an Employee Stock Options Plan (ESOP). It details the number of shares allotted, the increase in issued share capital, and compliance with SEBI regulations. There are no financial statements or comprehensive financial data presented, nor is this a report or presentation. The document is an official announcement of a share allotment event under ESOP, which fits the category of Share Issue/Capital Change (SHA). The document length is under 5,000 characters and contains detailed information about the share allotment, not just a notice of a report publication or certification. Therefore, the appropriate classification is SHA.
2023-06-02 English
Annual Secretarial Compliance Report
Regulatory Filings
2023-05-30 English
Pursuant to Regulation 24A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI circular no. CIR/CFD/CMD1/27/2019 dated 8th February, 2019, please ....
Regulatory Filings
2023-05-30 English
Updates
Regulatory Filings
2023-05-16 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of a newspaper advertisement of unaudited financial results for the quarter and year ended March 31, 2023. It references Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions that the advertisement was published in newspapers. The document itself is short (1326 characters) and serves as a notification or announcement that the financial results advertisement has been published, rather than containing the full financial results or detailed financial statements. Therefore, it is an announcement related to the publication of financial results, not the financial report itself. According to the rules, such a document should be classified as a Regulatory Filing (RNS) because it is a regulatory announcement and does not contain substantive financial data or the full report.
2023-05-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.